Project Description
Author: Basher et al.
Summary:
Status: Ongoing
Full text link: Not available
Immunogenicity and safety of two WHO approved post-exposure rabies vaccine intradermal (ID) regimens: the 4-site one-month compared with the 2-site one week regimen- An open-label head-to-head randomized clinical trialarif2024-01-05T18:23:00+00:00
